A preprint report of neutralizing antibody tests against omicron came out, concluding that more than 85% of the existing mab libraries did not inhibit omicron, including the newly released astrazeneca's tixagevimab + cilgavimab mab. expressionless_face, only sotrovivab is sufficent.